CLINICAL_TRIALS
trial_result
· 2011-03-11
Clinical Trial Update: Clinical Effectiveness of 10 cm^2 Rivastigmine Patch in Patients With Alzheimer's Disease [Phase 4]
Summary
Phase 4 trial results evaluating the clinical effectiveness of a 10 cm^2 rivastigmine transdermal patch in Alzheimer's disease have been reported.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Novartis | Conditions: Alzheimer's Disease | Phase 4 | Status: COMPLETED | Results posted: 2011-03-11